{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:58:41Z","timestamp":1773694721153,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1097\/igc.0b013e3182229ad8","type":"journal-article","created":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T14:29:57Z","timestamp":1309444197000},"page":"1185-1190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Utility of Tumor Marker HE4 to Predict Depth of Myometrial Invasion in Endometrioid Adenocarcinoma of the Uterus"],"prefix":"10.1016","volume":"21","author":[{"given":"Richard G.","family":"Moore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig Michael","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy K.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katina","family":"Robison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Steinhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geralyn","family":"Lambert-Messerlian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e3182229ad8_bb0005","series-title":"Cancer Facts and Figures 2010","first-page":"1","author":"American Cancer Society","year":"2010"},{"issue":"2 Pt 1","key":"10.1097\/IGC.0b013e3182229ad8_bb0010","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/AOG.0b013e318162f690","article-title":"Endometrial cancer","volume":"111","author":"Sorosky","year":"2008","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/107327480901600104","article-title":"The role of comprehensive surgical staging in patients with endometrial cancer","volume":"16","author":"Frederick","year":"2009","journal-title":"Cancer Control."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0020","first-page":"1","article-title":"Management of endometrial cancer","volume":"65","author":"Orr","year":"2005","journal-title":"ACOG Pract Bull."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0025","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ygyno.2006.10.013","article-title":"Endometrial cancerVrevisiting the importance of pelvic and para aortic lymph nodes","volume":"104","author":"Aalders","year":"2007","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0030","first-page":"20","article-title":"Complications of pelvic lymphadenectomy: do the risks outweigh the benefits?","volume":"12","author":"Loeb","year":"2010","journal-title":"Rev Urol."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/gyno.1998.5098","article-title":"Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma","volume":"70","author":"Mohan","year":"1998","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0040","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/gyno.1998.5254","article-title":"Lymph node sampling and survival in endometrial cancer","volume":"71","author":"Trimble","year":"1998","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/gyno.1995.1005","article-title":"Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling","volume":"56","author":"Kilgore","year":"1995","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0050","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/cncr.22185","article-title":"Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients","volume":"107","author":"Chan","year":"2006","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0055","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejso.2006.09.035","article-title":"Omission of lymphadenectomy is possible for low-risk corpus cancer","volume":"33","author":"Hidaka","year":"2007","journal-title":"Eur J Surg Oncol."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0060","first-page":"CD007585","article-title":"Lymphadenectomy for the management of endometrial cancer","author":"May","year":"2010","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4065\/83.1.97","article-title":"Current issues in the management of endometrial cancer","volume":"83","author":"Bakkum-Gamez","year":"2008","journal-title":"Mayo Clin Proc."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0070","first-page":"692","article-title":"Computed tomography in endometrial carcinoma","volume":"95","author":"Connor","year":"2000","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0075","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ygyno.2004.08.009","article-title":"Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer","volume":"95","author":"Horowitz","year":"2004","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0080","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1148\/radiol.2312021184","article-title":"Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning","volume":"231","author":"Manfredi","year":"2004","journal-title":"Radiology."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0085","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050232","article-title":"Ovarian carcinoma subtypes are different diseases: implications for biomarker studies","volume":"5","author":"Kobel","year":"2008","journal-title":"PLoS Med."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0095","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Hellstrom","year":"2003","journal-title":"Cancer Res."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(06)70579-4","article-title":"Proteins with whey-acidic-protein motifs and cancer","volume":"7","author":"Bouchard","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1465-9921-7-61","article-title":"WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung","volume":"7","author":"Bingle","year":"2006","journal-title":"Respir Res."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0110","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2008.04.002","article-title":"Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus","volume":"110","author":"Moore","year":"2008","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijgo.2009.02.010","article-title":"Revised FIGO staging for carcinoma of the endometrium","volume":"105","author":"Creasman","year":"2009","journal-title":"Int J Gynaecol Obstet."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0125","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1067\/mob.2000.106251","article-title":"125 in endometrial cancer: is it useful?","volume":"182","author":"Dotters","year":"2000","journal-title":"Am J Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182229ad8_bb0135","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","article-title":"Comprehensive analysis of HE4 expression in normal and malignant human tissues","volume":"19","author":"Galgano","year":"2006","journal-title":"Mod Pathol."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24056500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24056500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.lww.com\/ijgc\/Fulltext\/10.1097\/IGC.0b013e3182229ad8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:13:04Z","timestamp":1753233184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24056500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1048891X24056500"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e3182229ad8","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of Tumor Marker HE4 to Predict Depth of Myometrial Invasion in Endometrioid Adenocarcinoma of the Uterus","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e3182229ad8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2011 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}